CRIS Current Research Information System

FUSAROLI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 750
NA - Nord America 608
AS - Asia 354
AF - Africa 53
OC - Oceania 15
SA - Sud America 3
Totale 1.783
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 599
IT - Italia 416
SG - Singapore 159
CN - Cina 113
SE - Svezia 73
DE - Germania 70
IN - India 49
GB - Regno Unito 36
IE - Irlanda 32
CI - Costa d'Avorio 26
BG - Bulgaria 24
CH - Svizzera 22
FI - Finlandia 22
TG - Togo 21
ID - Indonesia 18
RU - Federazione Russa 17
CA - Canada 9
FR - Francia 8
NZ - Nuova Zelanda 8
AU - Australia 7
NL - Olanda 7
ES - Italia 4
HK - Hong Kong 4
PT - Portogallo 4
JO - Giordania 3
JP - Giappone 3
PL - Polonia 3
RS - Serbia 3
AT - Austria 2
LT - Lituania 2
MA - Marocco 2
NG - Nigeria 2
PE - Perù 2
SI - Slovenia 2
TH - Thailandia 2
ZA - Sudafrica 2
BA - Bosnia-Erzegovina 1
BR - Brasile 1
CZ - Repubblica Ceca 1
GR - Grecia 1
LK - Sri Lanka 1
MY - Malesia 1
TR - Turchia 1
Totale 1.783
Salva come PNG Salva come JPEG
Città #
Bologna 164
Singapore 140
Santa Clara 81
Chandler 74
Boardman 40
Milan 35
Dublin 32
Princeton 28
Abidjan 26
Ashburn 26
Redmond 24
Sofia 24
Southend 24
Lomé 21
Bern 19
Jakarta 18
Helsinki 17
Modena 15
New York 13
Fairfield 12
Los Angeles 10
San Diego 9
Shanghai 9
Florence 8
Monselice 8
Turin 8
Cesena 7
Guangzhou 7
Auckland 6
Beijing 6
Berlin 6
Cambridge 6
Embrun 6
Mercato Saraceno 6
Palermo 6
Rome 6
Seattle 6
Shenzhen 6
Verona 6
Houston 5
Hyderabad 5
Jinan 5
Lappeenranta 5
London 5
Mülheim 5
Pune 5
Ann Arbor 4
Boydton 4
Bühl 4
Casalecchio di Reno 4
Casalgrande 4
Chengdu 4
Des Moines 4
Melbourne 4
Taizhou 4
Woodbridge 4
Amman 3
Bentivoglio 3
Brescia 3
Cologne 3
Dallas 3
Forlì 3
Lisbon 3
Newcastle 3
Nijmegen 3
Novi Sad 3
Tredozio 3
Vaggeryd 3
Xi'an 3
Yokohama 3
Abeokuta 2
Arequipa 2
Bangkok 2
Castilenti 2
Cava De' Tirreni 2
Cernusco sul Naviglio 2
Chicago 2
Cinisello Balsamo 2
Dalian 2
Dübendorf 2
Düsseldorf 2
Ferrara 2
Gislaved 2
Gurugram 2
Hamilton 2
Hangzhou 2
Hong Kong 2
Kerken 2
La Spezia 2
Ljubljana 2
Maenza 2
Medford 2
Messina 2
Milwaukee 2
Moscow 2
Mumbai 2
Mönchengladbach 2
Naples 2
New Haven 2
Olalla 2
Totale 1.142
Salva come PNG Salva come JPEG
Nome #
Modified-Chronic Disease Score (M-CDS): Predicting the individual risk of death using drug prescriptions 161
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment 98
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System 87
Behavioral excess and disruptive conduct: A historical and taxonomic approach to the origin of the ‘impulse control disorders’ diagnostic construct 84
Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System 82
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems 77
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System 71
Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry 71
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System 70
Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System 67
Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System 65
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study 62
Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysis 60
Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list 57
Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19 52
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System 51
Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance 50
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 47
Serious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting system 45
Thromboembolic Events with Cyclin-Dependent Kinase 4/6 Inhibitors in the FDA Adverse Event Reporting System 44
What Is the Safety Profile of Cannabis-Based Medications? Analysis of the Post-Marketing Signals from the FDA Adverse Event Reporting System 44
Authors’ Reply to Robert P. Giugliano and Colleagues’ Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance” 41
Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic Appraisal 41
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco-toxicological data to assess and potentially mitigate their diffusion to water supplies 38
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS 38
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study 37
Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors 33
Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase® Spontaneous Reporting System 29
The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System 28
Post-marketing safety profile of cannabis products: Signals from the FDA adverse event reporting system 27
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians 26
Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database 25
Assessment of Reported Adverse Events After Interchanging Between TNF-α Inhibitor Biosimilars in the WHO Pharmacovigilance Database 16
Identifying Medications Underlying Communication Atypicalities in Psychotic and Affective Disorders: A Pharmacovigilance Study Within the FDA Adverse Event Reporting System 13
Real-world evidence and pharmacovigilance: workshop of the Italian Epidemiological Association and of the Italian Society of Pharmacology 13
Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach 13
Transparency and robustness of safety signals 9
Interpretation of Pharmacovigilance Disproportionality Analyses 7
Totale 1.879
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.525
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.525
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 1 8 11 8 1 7
2021/2022256 1 0 7 10 10 10 36 47 20 21 58 36
2022/2023478 36 19 31 32 48 38 45 48 81 14 54 32
2023/2024420 36 41 41 56 43 60 22 39 15 30 30 7
2024/2025689 93 139 165 104 129 59 0 0 0 0 0 0
Totale 1.879